Advanced Search

Study Preview



Study Title and Description

Risk factors for breast cancer according to estrogen and progesterone receptor status.



Key Questions Addressed
1 Key Question 1. In adult women without preexisting breast cancer, what is the accuracy of risk assessment methods to identify women who could benefit from medications to reduce risk for primary breast cancer (e.g., clinical risk assessment models)? Key Question 1a. What is the optimal age at which to begin risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer? Key Question 1b. What is the optimal frequency of risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Risk factors for breast cancer according to estrogen and progesterone receptor status.
Author Colditz GA., Rosner BA., Chen WY., Holmes MD., Hankinson SE.
Country Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center, and Channing Laboratory, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115-5899, USA. graham.colditz@channing.harvard.edu
Year 2004
Numbers Pubmed ID: 14759989

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.